@article{oai:repo.qst.go.jp:00085190,
 author = {Tomoteru, Yamasaki and Maki, Okada and Atsuto, Hiraishi and Wakana, Mori and Zhang, Yiding and Masayuki, Fujinaga and Hidekatsu, Wakizaka and Kurihara, Yusuke and Nobuki, Nengaki and Zhang, Ming-Rong and Tomoteru, Yamasaki and Maki, Okada and Atsuto, Hiraishi and Wakana, Mori and Zhang, Yiding and Masayuki, Fujinaga and Hidekatsu, Wakizaka and Kurihara, Yusuke and Nobuki, Nengaki and Zhang, Ming-Rong},
 journal = {Neurotoxicity Resesarch},
 month = {Jan},
 note = {Aim of this study is to investigate the changes in expression of metabotropic glutamate (Glu) receptor subtype 1 (mGluR1), a key molecule involved in neuroexcitetoxicity, during excessive Glu release in the brain by PET imaging. An animal model of excessive Glu release in the brain was produced by intraperitoneally implanting an Alzet osmotic pump containing N-acetylcysteine (NAC), an activator of the cysteine/Glu antiporter, into the abdomen of rats. Basal Glu concentration in the brain was measured by microdialysis, which showed that basal Glu concentration in NAC-treated rats (0.31 µM) was higher than that in saline-treated rats (0.17 µM) at day 7 after the implantation of the osmotic pump. Similarly, PET studies with [11C]ITDM, a useful radioligand for mGluR1 imaging exhibited that the striatal binding potential (BPND) of [11C]ITDM for mGluR1 in PET assessments was increased in NAC-treated animals at day 7 after implantation (2.30) compared with before implantation (1.92). The dynamic changes in striatal BPND during the experimental period were highly correlated with basal Glu concentration. In conclusion, density of mGluR1 is rapidly upregulated by increases in basal Glu concentration, suggesting that mGluR1 might to be a potential biomarker of abnormal conditions in the brain.},
 pages = {26--35},
 title = {Upregulation of striatal metabotropic glutamate receptor subtype 1 (mGluR1) in rats with excessive glutamate release induced by N-acetylcysteine},
 volume = {40},
 year = {2022}
}